Development of multiplex digital PCR assays for the detection of PIK3CA mutations in the plasma of metastatic breast cancer patients
Abstract With the approval of new therapies targeting the PI3K pathway, the detection of PIK3CA mutations has become a key factor in treatment management for HR+/HER2− metastatic breast cancer (MBC). We developed multiplex digital PCR (dPCR) assays to detect and quantify PIK3CA mutations. A first sc...
Enregistré dans:
Auteurs principaux: | Julien Corné, Fanny Le Du, Véronique Quillien, Florence Godey, Lucie Robert, Héloïse Bourien, Angélique Brunot, Laurence Crouzet, Christophe Perrin, Claudia Lefeuvre-Plesse, Véronique Diéras, Thibault De la Motte Rouge |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/493c25d955e1403bb36fc1a721cea902 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
par: Li Chen, et autres
Publié: (2018) -
Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma
par: H. Halse, et autres
Publié: (2018) -
The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer. October 16th, 2020. Event review
par: Irina V. Poddubnaya, et autres
Publié: (2021) -
Overexpression of PIK3R1 promotes hepatocellular carcinoma progression
par: Ai,Xuejun, et autres
Publié: (2018) -
A mutation in VPS15 (PIK3R4) causes a ciliopathy and affects IFT20 release from the cis-Golgi
par: Corinne Stoetzel, et autres
Publié: (2016)